Published in Proc Natl Acad Sci U S A on November 01, 1985
Mini-mu bacteriophage with plasmid replicons for in vivo cloning and lac gene fusing. J Bacteriol (1986) 4.45
Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J Bacteriol (1994) 2.97
Identification of residues in the Mu transposase essential for catalysis. Proc Natl Acad Sci U S A (1994) 1.94
DNA-protein complexes during attachment-site synapsis in Mu DNA transposition. EMBO J (1991) 1.49
Molecular cloning of Mu d(bla lacZ) transcriptional and translational fusions. J Bacteriol (1987) 1.41
Mutants of Escherichia coli defective for replicative transposition of bacteriophage Mu. J Bacteriol (1986) 1.33
Structural domains in phage Mu transposase: identification of the site-specific DNA-binding domain. Proc Natl Acad Sci U S A (1987) 1.29
DNA sequence of the control region of phage D108: the N-terminal amino acid sequences of repressor and transposase are similar both in phage D108 and in its relative, phage Mu. Nucleic Acids Res (1986) 1.09
Temperature-sensitive mutations in the bacteriophage Mu c repressor locate a 63-amino-acid DNA-binding domain. J Bacteriol (1991) 1.07
A domain sharing model for active site assembly within the Mu A tetramer during transposition: the enhancer may specify domain contributions. EMBO J (1995) 1.06
Solution structure of the Mu end DNA-binding ibeta subdomain of phage Mu transposase: modular DNA recognition by two tethered domains. EMBO J (1997) 0.98
Nucleotide sequences required for Tn3 transposition immunity. J Bacteriol (1989) 0.91
Altering the DNA-binding specificity of Mu transposase in vitro. Nucleic Acids Res (1998) 0.84
Mutational analysis of the att DNA-binding domain of phage Mu transposase. Nucleic Acids Res (1995) 0.82
In vitro maturation and encapsidation of the DNA of transposable Mu-like phage D108. Proc Natl Acad Sci U S A (1990) 0.78
Transposable prophage Mu is organized as a stable chromosomal domain of E. coli. PLoS Genet (2013) 0.78
Autoregulation of phage mu transposase at the level of translation. Nucleic Acids Res (1988) 0.77
Secondary structural features of the bacteriophage Mu-encoded A and B transposition proteins. Biochem J (1989) 0.76
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol (1978) 29.77
Protein-DNA recognition. Annu Rev Biochem (1984) 22.02
Automation of the computer handling of gel reading data produced by the shotgun method of DNA sequencing. Nucleic Acids Res (1982) 14.73
The operator-binding domain of lambda repressor: structure and DNA recognition. Nature (1982) 6.03
E. coli integration host factor binds to specific sites in DNA. Cell (1984) 5.81
Bacteriophage mu as a transposition element. Annu Rev Genet (1976) 5.66
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
Homology among DNA-binding proteins suggests use of a conserved super-secondary structure. Nature (1982) 5.21
Site-specific recognition of the bacteriophage Mu ends by the Mu A protein. Cell (1984) 3.33
An E. coli gene product required for lambda site-specific recombination. Cell (1980) 2.87
Structural similarity in the DNA-binding domains of catabolite gene activator and cro repressor proteins. Proc Natl Acad Sci U S A (1982) 2.84
Structure of catabolite gene activator protein at 2.9-A resolution. Incorporation of amino acid sequence and interactions with cyclic AMP. J Biol Chem (1982) 2.27
In vitro and in vivo manipulations of bacteriophage Mu DNA: cloning of Mu ends and construction of mini-Mu's carrying selectable markers. Gene (1981) 2.21
Nucleotide sequences of the attachment sites of bacteriophage Mu DNA. Nature (1979) 2.05
Nucleotide sequence of the immunity region of bacteriophage Mu. Mol Gen Genet (1982) 1.92
Many gene-regulatory proteins appear to have a similar alpha-helical fold that binds DNA and evolved from a common precursor. J Mol Evol (1983) 1.80
DNA sequences at the ends of the genome of bacteriophage Mu essential for transposition. Proc Natl Acad Sci U S A (1985) 1.71
The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51
Amplification and purification of the bacteriophage Mu encoded B transposition protein. J Biol Chem (1985) 1.43
Polypeptides encoded by the early region of bacteriophage Mu synthesized in minicells of Escherichia coli. J Mol Biol (1981) 1.40
Cloning of the A gene of bacteriophage Mu and purification of its product, the Mu transposase. J Biol Chem (1985) 1.32
Mutator bacteriophage D108 and its DNA: an electron microscopic characterization. J Virol (1981) 1.24
The products of gene A of the related phages Mu and D108 differ in their specificities. Mol Gen Genet (1983) 1.21
Switch in the transposition products of Mu DNA mediated by proteins: Cointegrates versus simple insertions. Proc Natl Acad Sci U S A (1983) 1.12
Crystallographic structure of Rhodospirillum molischianum ferricytochrome c' at 2.5 A resolution. J Mol Biol (1981) 0.93
End labeling of enzymatically decapped mRNA. Nucleic Acids Res (1977) 6.58
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (1993) 5.78
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. J Mol Biol (1982) 4.11
The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature (1984) 4.05
5'-32P labeling of RNA and DNA restriction fragments. Methods Enzymol (1980) 3.83
Structure of the fibre-forming protein pilin at 2.6 A resolution. Nature (1995) 3.70
Structure of a protein photocycle intermediate by millisecond time-resolved crystallography. Science (1997) 3.25
1.4 A structure of photoactive yellow protein, a cytosolic photoreceptor: unusual fold, active site, and chromophore. Biochemistry (1995) 3.15
Structure at 0.85 A resolution of an early protein photocycle intermediate. Nature (1998) 2.98
Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science (1998) 2.75
Transpososomes: stable protein-DNA complexes involved in the in vitro transposition of bacteriophage Mu DNA. Cell (1987) 2.73
The beta bulge: a common small unit of nonrepetitive protein structure. Proc Natl Acad Sci U S A (1978) 2.72
Differentiation of Serratia marcescens 274 into swimmer and swarmer cells. J Bacteriol (1990) 2.66
Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol (2000) 2.63
Structural aspects of a higher order nucleoprotein complex: induction of an altered DNA structure at the Mu-host junction of the Mu type 1 transpososome. EMBO J (1991) 2.46
Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature (1984) 2.36
Photoactive yellow protein: a structural prototype for the three-dimensional fold of the PAS domain superfamily. Proc Natl Acad Sci U S A (1998) 2.26
The effect on blood-pressure of organ extracts. J Physiol (1911) 2.24
In vitro and in vivo manipulations of bacteriophage Mu DNA: cloning of Mu ends and construction of mini-Mu's carrying selectable markers. Gene (1981) 2.21
The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science (1997) 2.18
A mechanism of DNA transposition. Proc Natl Acad Sci U S A (1981) 2.14
Structure of the I1 early intermediate of photoactive yellow protein by FTIR spectroscopy. Nat Struct Biol (2001) 2.14
Structure and mechanism of copper, zinc superoxide dismutase. Nature (1984) 2.06
Fluorescent treponemal antibodies in fractionated syphilitic sera. The immunoglobulin class. Arch Dermatol (1969) 2.06
Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc Natl Acad Sci U S A (1985) 1.97
Salmonella enterica serovar typhimurium swarming mutants with altered biofilm-forming abilities: surfactin inhibits biofilm formation. J Bacteriol (2001) 1.97
Complete chemical structure of photoactive yellow protein: novel thioester-linked 4-hydroxycinnamyl chromophore and photocycle chemistry. Biochemistry (1994) 1.93
The chemotaxis system, but not chemotaxis, is essential for swarming motility in Escherichia coli. Proc Natl Acad Sci U S A (1998) 1.93
pepM is an essential gene in Salmonella typhimurium. J Bacteriol (1989) 1.85
Interaction of distinct domains in Mu transposase with Mu DNA ends and an internal transpositional enhancer. Nature (1989) 1.82
Chemistry of antibody binding to a protein. Science (1987) 1.82
End group labelling of RNA and double stranded DNA by phosphate exchange catalyzed by bacteriophage T4 induced polynucleotide kinase. Biochem Biophys Res Commun (1975) 1.80
Step-arrest mutants of FLP recombinase: implications for the catalytic mechanism of DNA recombination. Mol Cell Biol (1988) 1.78
Mutations that impair swarming motility in Serratia marcescens 274 include but are not limited to those affecting chemotaxis or flagellar function. J Bacteriol (1992) 1.76
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
A protein factor which reduces the negative supercoiling requirement in the Mu DNA strand transfer reaction is Escherichia coli integration host factor. J Biol Chem (1989) 1.66
Predominant end-products of prophage Mu DNA transposition during the lytic cycle are replicon fusions. J Mol Biol (1981) 1.66
N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66
Mutational analysis of flagellum-independent surface spreading of Serratia marcescens 274 on a low-agar medium. J Bacteriol (1995) 1.60
Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem (1994) 1.60
Effect of speaking rate on the perceptual structure of a phonetic category. Percept Psychophys (1989) 1.59
Active site mutants implicate key residues for control of color and light cycle kinetics of photoactive yellow protein. Biochemistry (1997) 1.59
Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol (1999) 1.57
Flagellar variation in Serratia marcescens is associated with color variation. J Bacteriol (1987) 1.57
Mechanisms of antibody binding to a protein. Science (1987) 1.55
Structural basis for the root effect in haemoglobin. Nat Struct Biol (1996) 1.55
Rate of ribonucleic acid chain growth in Mycobacterium tuberculosis H37Rv. J Bacteriol (1977) 1.54
Articulation rate and its variability in spontaneous speech: a reanalysis and some implications. Phonetica (1984) 1.52
The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51
Evolutionary conservation of methyl-accepting chemotaxis protein location in Bacteria and Archaea. J Bacteriol (2000) 1.50
The TPI and FTA-ABS tests in treated late syphilis. JAMA (1968) 1.50
Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol (1992) 1.50
The structural biochemistry of the superoxide dismutases. Biochim Biophys Acta (2009) 1.50
Sulfite reductase structure at 1.6 A: evolution and catalysis for reduction of inorganic anions. Science (1995) 1.49
A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49
Site-specific HU binding in the Mu transpososome: conversion of a sequence-independent DNA-binding protein into a chemical nuclease. Genes Dev (1993) 1.49
Some effects of later-occurring information on the perception of stop consonant and semivowel. Percept Psychophys (1979) 1.47
Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45
Crystallographic structure of a photoreceptor protein at 2.4 A resolution. Proc Natl Acad Sci U S A (1989) 1.45
Amplification and purification of the bacteriophage Mu encoded B transposition protein. J Biol Chem (1985) 1.43
Epidurals redefined in analgesia and anesthesia: a distinction with a difference. J Obstet Gynecol Neonatal Nurs (1996) 1.42
The North American experience with photopheresis. Ther Apher (1999) 1.42
Anatomy of a flexer-DNA complex inside a higher-order transposition intermediate. Cell (1996) 1.41
GnRH agonists: gonadorelin, leuprolide and nafarelin. Am Fam Physician (1991) 1.40
The atomic mobility component of protein antigenicity. Annu Rev Immunol (1985) 1.40
Holliday junctions in FLP recombination: resolution by step-arrest mutants of FLP protein. Proc Natl Acad Sci U S A (1988) 1.40
Marrow aplasia and sulindac. Ann Intern Med (1980) 1.40
Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol (2009) 1.39
GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39
The interdependence of protein surface topography and bound water molecules revealed by surface accessibility and fractal density measures. J Mol Biol (1992) 1.39
Finasteride for benign prostatic hyperplasia. Am Fam Physician (1992) 1.38
Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium. Proc Natl Acad Sci U S A (1995) 1.37
Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry (1990) 1.36
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry (1997) 1.36
Phonetic prototypes: influence of place of articulation and speaking rate on the internal structure of voicing categories. J Acoust Soc Am (1992) 1.35
Genetically engineered polymers of human CuZn superoxide dismutase. Biochemistry and serum half-lives. J Biol Chem (1989) 1.32
Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies. Infect Immun (1996) 1.29
Structural domains in phage Mu transposase: identification of the site-specific DNA-binding domain. Proc Natl Acad Sci U S A (1987) 1.29
Metalloantibodies. Science (1990) 1.27
Infecting bacteriophage mu DNA forms a circular DNA-protein complex. J Mol Biol (1983) 1.26
The Mu transpositional enhancer can function in trans: requirement of the enhancer for synapsis but not strand cleavage. Cell (1992) 1.26
Screening a peptidyl database for potential ligands to proteins with side-chain flexibility. Proteins (1998) 1.25
Immunoelectron microscopic analysis of the A, B, and HU protein content of bacteriophage Mu transpososomes. J Biol Chem (1990) 1.25
Action at a distance in Mu DNA transposition: an enhancer-like element is the site of action of supercoiling relief activity by integration host factor (IHF). EMBO J (1989) 1.24
Treated late syphilis: immunoglobulin class of antibodies reactive with Treponema pallidum. J Invest Dermatol (1969) 1.24
Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem (1997) 1.23
The role of arginine 143 in the electrostatics and mechanism of Cu,Zn superoxide dismutase: computational and experimental evaluation by mutational analysis. Proteins (1994) 1.23
Erosive arthritis associated with apatite crystal deposition. Arthritis Rheum (1981) 1.22
The bacteriophage Mu N gene encodes the 64-kDa virion protein which is injected with, and circularizes, infecting Mu DNA. J Biol Chem (1986) 1.21